Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis

AIMS: Several studies reported treatment benefits of tolvaptan in patients with congestive heart failure (CHF). However, the optimal dosage remains unclear. We aimed to compare different dosage of tolvaptan to determine the optimal dosage in terms of the efficacy and safety. METHODS: We searched MED...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS One
Asıl Yazarlar: Wu, Mei-Yi, Chen, Tzu-Ting, Chen, Ying-Chun, Tarng, Der-Cherng, Wu, Yun-Chun, Lin, Hsien-Ho, Tu, Yu-Kang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2017
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5595312/
https://ncbi.nlm.nih.gov/pubmed/28898297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0184380
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller